PRISM BioLab Co.,LTD Ratios and Metrics

Market cap in millions JPY. Fiscal year is October - September.

Millions JPY. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 5, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022
Market Capitalization	7,128	6,161	14,741	-	-
Market Cap Growth	-30.68%	-58.21%	-	-	-
Enterprise Value	4,307	2,858	11,671	-	-
Last Close Price	193.00	168.00	410.00	-	-
PS Ratio	10.41	9.10	48.24	-	-
PB Ratio	2.92	2.27	4.21	-	-
P/TBV Ratio	2.92	2.27	4.21	-	-
P/OCF Ratio	-	-	98.18	-	-
EV/Sales Ratio	6.29	4.22	38.19	-	-
Net Debt / Equity Ratio	-1.16	-1.08	-1.25	-0.99	-1.01
Net Debt / EBITDA Ratio	-	-	5.68	2.32	-
Net Debt / FCF Ratio	-	1.90	78.93	2.07	-
Asset Turnover	0.19	0.18	0.11	0.08	-
Quick Ratio	5.18	8.02	4.36	18.57	26.28
Current Ratio	5.31	8.21	4.40	18.94	26.65
Return on Equity (ROE)	-32.14%	-26.84%	-45.13%	-37.33%	-
Return on Assets (ROA)	-14.17%	-12.71%	-17.04%	-21.04%	-
Return on Invested Capital (ROIC)	-	-	-	-92699.25%	-
Return on Capital Employed (ROCE)	-33.60%	-28.50%	-22.30%	-43.30%	4.00%
Earnings Yield	-13.02%	-13.53%	-7.12%	-	-
FCF Yield	-	-24.88%	-0.38%	-	-
Buyback Yield / Dilution	-11.06%	-16.70%	-13.40%	-0.94%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.